Resistance study of community respiratory pathogens isolated in China from 2005 to 2007

National Medical Journal of China

Volumn 89, Issue 42, 2009, Pages 2983-2987

  Sun, Hong Li ^a   Yang, Qi Wen ^a   Xu, Ying Chun ^a   Wang, Hui ^a   Xie, Xiu Li ^a   Chen, Min Jun ^a   Zhang, Xiu Zhen ^b   Liu, Yong ^b   Ye, Hui Fen ^b   Sun, Zi Yong ^b   Duan, Qiong ^b   Ni, Yu Xing ^b   Yu, Yun Song ^b   Zhao, Wang Sheng ^b   He, Lin ^b   Wang, Jing ^b   Ji, Ping ^b   Liu, Peng Peng ^b   Zhang, Li Xia ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NONE

Author keywords

Bacteria; Community acquired infections; Drug resistance; Respiratory tract infections

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CHINA; COMMUNICABLE DISEASE; DRUG EFFECT; HAEMOPHILUS INFLUENZAE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MORAXELLA CATARRHALIS; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHINA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 80052037718     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.42.010     Document Type: Article

References (9)

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests Approved standard, document M02-A9. Wayne: Clinical and Laboratory Standards Institute, 2006, 1-37.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement, document M100-S19. Wayne, Clinical and Laboratory Standards Institute, 2009.
3. Lee NY, Song JH, Kim S, et al, Carriage of antibiotic-resistant pneumococci among Asian children; a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin Infec Dis, 2001, 32: 1463-1469.
4. Jones RN, Sader HS, Fritsche TR, et al. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis, 2007, 57: 109-116.
5. Inoue, M Kaneko K, Akizawa K, et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT year 1-3(1999-2002). J Infect Chemother, 2006, 12: 9-21.
6. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother, 2004, 48: 2101-2107.
7. Farrell DJ, Jenkins SG. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002. J Antimicrobial Chemotherapy, 2004, 54 Suppl 1: i17-22.
8. Felmingham D, Ralf Rene Reinert, Yoichi Hirakata, et al.Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother, 2002, 50 Suppl S1: 25-37.
9. 2002, 25: 137-140.